AVBP Exercise Disclosure
Lachapelle Robin · SEC Form 4 · Filed Nov 2, 2026
Exercise
Calculated transaction value
$0
Lachapelle Robin Chief Operating Officer
AVBP
ArriVent BioPharma
AVBP
Transaction date
Oct 30, 2026
Public filing date
Nov 2, 2026
Filing lag
Filed 3 days later
AVBP daily price context
Close on/before transaction
$14.87
Oct 30, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 16,265 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001104659-26-121410
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$184.9K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Arrivent Biopharma, Inc. AVBP | Exercise | Oct 30, 2026 | $110.05K |
| Arrivent Biopharma, Inc. AVBP | Exercise | Oct 30, 2026 | $4.15K |
| Arrivent Biopharma, Inc. AVBP | Exercise | Oct 30, 2026 | $0 |
| Arrivent Biopharma, Inc. AVBP | Exercise | Oct 30, 2026 | $59.37K |
| Arrivent Biopharma, Inc. AVBP | Exercise | Oct 30, 2026 | $10.38K |
| Arrivent Biopharma, Inc. AVBP | Exercise | Oct 30, 2026 | $935.42 |
| Arrivent Biopharma, Inc. AVBP | Exercise | Oct 30, 2026 | $0 |
| Arrivent Biopharma, Inc. AVBP | Exercise | Oct 30, 2026 | $0 |
| Arrivent Biopharma, Inc. AVBP Current | Exercise | Oct 30, 2026 | $0 |
| Arrivent Biopharma, Inc. AVBP | Exercise | Oct 30, 2026 | $0 |